1/7 Great question, relevant to everyone: Simple answer: 1- none of your children will have high Lp(a) 2- if both your parents have Lp(a) <15, no siblings w/⏫ Lp(a) 3- If one parent has ⏫Lp(a), then ~50% of siblings w/ ⏫Lp(a) 4- if both parents have ⏫Lp(a), then ~75%-100%

Best friend and Cardiology fellow 🫀

Ther is a 1:1 relationship of apoB to Lp(a), so an Lp(a) level of 125 nmol/L means the apoB on Lp(a) is also 125 nmol/L. To convert apoB of Lp(a) to mg/dl divide by 19.49. In this case apoB of Lp(a) is 125 nmol/L/19.49= 6.4 mg/dL. If your apoB is 70 mg/dL, it means 63.6 mg/dL is

Two new articles came out in JACC Journals today: Each suggested Lp(a) is ~6x more atherogenic than LDL-C when evaluated per apoB. Vera Bittner and I provide commentary how to put this in clinical context with atherogenicity vs # of particles. jacc.org/doi/10.1016/j.…

On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Genetic Analysis Do you know your Lp(a)? I do ... jacc.org/doi/10.1016/j.…

Pleased to be able to contribute and by the widespread interest in Lp(a)

Started the year with an in depth review of the obesity paradox. WeTouched on limitations of BMI & importance of cardio-respiratory fitness as a prognostic tool in HF. Grateful to amazing mentors Anurag Mehta & Salvatore Carbone, PhD, RDN, FHFSA, FASPEN for the opportunity and guidance. doi.org/10.1016/j.pcad…

🧵 Just published: USPSTF recommends all women undergo routine #breastcancer screening every other year beginning at age 40, an update from the 2016 recommendation to start at age 50. ja.ma/3WmvqEO

Throwback #ACC24 American College of Cardiology Association of Black Cardiologists……Cardiovascular medicine enthusiasts

Looking forward to serving on the board & working with the exceptional team ASPC to Promote the Prevention of Cardiovascular Disease Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Michael D. Shapiro David Maron Alison L. Bailey, MD

New insights on life-threatening arrhythmias in Takotsubo Syndrome. Explore the complex mechanisms and innovative treatments. 🇮🇹🇺🇸 Link: sciencedirect.com/science/articl… giulia_lavecchia Marco Del Buono Paula Rodriguez Miguelez Jordana Kron Tommaso Sanna AntonioAbbate

And for the last treat of the day, Lp(a) and Sam Tsimikas are moving into the heart failure field. Lp(a), likely via its OxPL content, is associated with progression of heart faluure and CVD death. Study led by @JJheart_doc and Pradeep Natarajan There is also data from MESA, more to

Great meeting these beautiful minds at the #ASPC2024 Congress on CVD prevention in Salt Lake City Utah!! Pamela Alebna MD MPH Grace Patrice Anyetei-Anum Mathias Lalika, MD, MPH . We had a great time!!

Awesome weekend learning from experts in preventative cardiology and making lifelong friends! #ASPC2024 Mathias Lalika, MD, MPH Pamela Alebna MD MPH mark anthony ntow

A few weeks ago ASPC 2024. Met old friends and made some news ones. Grateful for an amazing team!

It was a wonderful weekend at #AHA24! Presented my research, made new friends and the best part-reconnecting with old ones. Thankful for great mentors Anurag Mehta and Fadi N Salloum. Walter A Albert Danso Osei

An important paper ⁦JACC Journals⁩ #JACCAdvances showing in a meta analysis that the risk of Lp(a) is not modified by hsCRP ⁦Anurag Mehta⁩ ⁦Pamela Alebna MD MPH⁩ sciencedirect.com/science/articl…

Great study led by VCU Health Pauley Heart Center T-32 cardiology fellow Pamela Alebna MD MPH

Our new study on the AHA PREVENT Equations and Lp(a) is out now JAMA Cardiology Alexander C. Razavi JaredSpitzMD Jaideep Michael D. Shapiro Sam Tsimikas, MD Anurag Mehta UC San Diego Cardiology UC San Diego Cardiology Fellows ASPC Family Heart Foundation #KnowLpa Key Points in the thread below:

📉Lower LDL-C for longer is better. The NLA’s new guidance simplifies LDL-C management for adults — helping clinicians & patients improve evidence-based measurement and treatment of LDL-C. Read the guidelines & recommendations: lipidjournal.com/article/S1933-…. Beth Jackson Christie Ballantyne